Resumen
Mice are used as model organisms to understand the pathological basis of a variety of human diseases, including breast cancer. Both immunocompetent and immunocompromised mouse models are used depending on the scope of the study. Immunocompetent models allow the study of the impact of the immune system in murine models of mammary cancer, while immunodeficient mice serve as ideal host organisms to understand the behavior of human breast cancers within a biological system. Xenografting of human breast cancer cells into immunocompromised mouse models continues to be the most used fundamental animal model in preclinical breast cancer research. These in vivo models allow critical understanding of tumor biology and assessment of novel treatments, a necessary prelude to testing new drugs in the clinic. In this chapter, we provide detailed methodology for the use of non-obese diabetic (NOD) severe combined immunodeficient (SCID) mice in several breast cancer xenografting procedures, including established cell lines and patient-derived xenografts (PDXs).
Idioma original | English |
---|---|
Páginas (desde-hasta) | 31-44 |
Número de páginas | 14 |
Publicación | Methods in Molecular Biology |
Volumen | 2508 |
DOI | |
Estado | Published - 2022 |
Nota bibliográfica
Publisher Copyright:© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
ASJC Scopus Subject Areas
- Molecular Biology
- Genetics
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't